Clinical characteristics, physiological features, and outcomes associated with hypercapnia in patients with acute hypoxemic respiratory failure due to COVID–19---insights from the PRoVENT–COVID study
Anissa M. Tsonas(Amsterdam UMC Location University of Amsterdam), Ary Serpa Neto(The University of Melbourne), Marcus J. Schultz(University of St.Gallen), Antonio Artigas(Instituto de Salud Carlos III), Janneke Horn(Amsterdam University Medical Centers), Michela Botta(Amsterdam University Medical Centers), Luis Morales–Quinteros(Universitat Autònoma de Barcelona), Frederique Paulus(Amsterdam University Medical Centers)
Cited by 17
Related Papers
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k
Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis
|JAMA|2003|958
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|737
Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study
|The Lancet Respiratory Medicine|2017|645